FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to the use of the composition as a neuroimmunomodulator. The use of a nutraceutical composition, which is a homogenized mixture of dry powders, in which the percentage by weight of dry powder of each ingredient from the total weight of the composition is,%: turmeric root extract 1-50, black pepper extract 0.2-1, soy extract 1-50 , green tea leaf extract 1-50, red root extract 1-50, licorice extract 1-50, sea buckthorn leaf extract 10-60, arabinogalactan 1-50 and zinc 0.1-0.5 as a neuroimmunomodulator.
EFFECT: above composition is effective as a neuroimmunomodulator.
1 cl, 1 dwg, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REDUCING ALCOHOLIC MOTIVATION IN MICE | 2020 |
|
RU2744411C1 |
IMMUNOMODULATOR | 2018 |
|
RU2691143C1 |
IMMUNOMODULATOR | 2019 |
|
RU2702114C1 |
METHOD FOR STIMULATING NEUROGENESIS IN THE HIPPOCAMPUS | 2017 |
|
RU2675111C2 |
MODULATOR OF BRAIN ACTIVITY IN AGE-RELATED MAMMALS | 2021 |
|
RU2758010C1 |
7-O-[6-O-(4-ACETYL-α-L-RHAMNOPYRANOSYL)-β-D-GLUCOPYRANOSIDO]-5-HYDROXY-6-METHOXY-2-(4-METHOXY-PHENYL)-4H-CHROMONE-4-ON, HAVING ANTI-ALCOHOL ACTION ON HIGHER NERVOUS ACTIVITY | 2014 |
|
RU2605377C2 |
METHOD FOR PREVENTING PROGRESSION AND RELIEVING INTENSITY OF ALCOHOLIC IMPULSE | 2011 |
|
RU2533233C2 |
17ALPHA,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE 17ALPHA,21-DIACETATE SHOWING ANTIALCOHOLIC AND ADAPTOGENIC ACTIVITY | 1999 |
|
RU2172173C2 |
REMEDY AGAINST PATHOLOGIC INCLINATION FOR ALCOHOLISM | 0 |
|
SU1828751A1 |
COMPOSITIONS, METHODS AND MEDICAL COMPOSITIONS FOR TREATMENT AND MAINTENANCE OF LIVER HEALTH | 2016 |
|
RU2755475C2 |
Authors
Dates
2021-05-18—Published
2020-05-13—Filed